Identification of a major histocompatibility complex class I-restricted T-cell epitope in the tumour-associated antigen, 5T4

Por Redchenko, Irina, Harrop, Richard, Ryan, Matthew G, Hawkins, Robert E, Carroll, Miles W
Publicado em 2006

Potential Limitations of the NSG Humanized Mouse as a Model System to Optimize Engineered Human T cell Therapy for Cancer

Por Alcantar-Orozco, Erik M., Gornall, Hannah, Baldan, Vania, Hawkins, Robert E., Gilham, David E.
Publicado em 2013

Immunological response and overall survival in a subset of advanced renal cell carcinoma patients from a randomized phase 2/3 study of naptumomab estafenatox plus IFN-α versus IFN-...

Por Elkord, Eyad, Burt, Deborah J., Sundstedt, Anette, Nordle, Örjan, Hedlund, Gunnar, Hawkins, Robert E.
Publicado no Oncotarget (2015)

Immunohistochemical assessment of NY-ESO-1 expression in esophageal adenocarcinoma resection specimens

Por Hayes, Stephen J, Hng, Keng Ngee, Clark, Peter, Thistlethwaite, Fiona, Hawkins, Robert E, Ang, Yeng
Publicado em 2014

Gene Delivery of a Mutant TGFβ3 Reduces Markers of Scar Tissue Formation After Cutaneous Wounding

Por Waddington, Simon N, Crossley, Rachel, Sheard, Vicky, Howe, Steven J, Buckley, Suzanne MK, Coughlan, Lynda, Gilham, David E, Hawkins, Robert E, McKay, Tristan R
Publicado em 2010

Adjuvant Weekly Girentuximab Following Nephrectomy for High-Risk Renal Cell Carcinoma: The ARISER Randomized Clinical Trial

Por Chamie, Karim, Donin, Nicholas M., Klöpfer, Pia, Bevan, Paul, Fall, Barbara, Wilhelm, Olaf, Störkel, Stephan, Said, Jonathan, Gambla, Michael, Hawkins, Robert E., Jankilevich, Gustavo, Kapoor, Anil, Kopyltsov, Evgeny, Staehler, Michael, Taari, Kimmo, Wainstein, Alberto J. A., Pantuck, Allan J., Belldegrun, Arie S.
Publicado no JAMA Oncol (2016)

The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent respirator...

Por Thistlethwaite, Fiona C., Gilham, David E., Guest, Ryan D., Rothwell, Dominic G., Pillai, Manon, Burt, Deborah J., Byatte, Andrea J., Kirillova, Natalia, Valle, Juan W., Sharma, Surinder K., Chester, Kerry A., Westwood, Nigel B., Halford, Sarah E. R., Nabarro, Stephen, Wan, Susan, Austin, Eric, Hawkins, Robert E.
Publicado no Cancer Immunol Immunother (2017)

Randomized Open-Label Phase II Trial of Apitolisib (GDC-0980), a Novel Inhibitor of the PI3K/Mammalian Target of Rapamycin Pathway, Versus Everolimus in Patients With Metastatic Re...

Por Powles, Thomas, Lackner, Mark R., Oudard, Stéphane, Escudier, Bernard, Ralph, Christy, Brown, Janet E., Hawkins, Robert E., Castellano, Daniel, Rini, Brian I., Staehler, Michael D., Ravaud, Alain, Lin, Wei, O’Keeffe, Bridget, Wang, Yulei, Lu, Shan, Spoerke, Jill M., Huw, Ling-Yuh, Byrtek, Michelle, Zhu, Rui, Ware, Joseph A., Motzer, Robert J.
Publicado no J Clin Oncol (2016)